Mineralys Therapeutics, Inc. |
Director, 10%+ Owner |
Common Stock |
5.07M |
$68.5M |
$13.50 |
Feb 12, 2024 |
Indirect |
Scholar Rock Holding Corp |
Director |
Common Stock |
6.79M |
$61M |
$8.99 |
Jun 27, 2024 |
By Samsara BioCapital, L.P. |
vTv Therapeutics Inc. |
Director, 10%+ Owner |
Pre- Funded Warrants (Right to Buy) |
834K |
$9.84M |
$11.80 |
Feb 27, 2024 |
Samsara BioCapital, L.P. |
vTv Therapeutics Inc. |
Director, 10%+ Owner |
Class A Common Stock |
266K |
$3.14M |
$11.81 |
Feb 27, 2024 |
By Samsara BioCapital, L.P. |
Scholar Rock Holding Corp |
Director |
Common Stock |
13.5K |
$121K |
$8.99 |
Jun 27, 2024 |
Direct |
vTv Therapeutics Inc. |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
3.75K |
$44.3K |
$11.81 |
Feb 27, 2024 |
Direct |
Syros Pharmaceuticals, Inc. |
Director |
Common Stock |
6.67K |
$33K |
$4.95 |
Jun 1, 2024 |
Direct |
Syros Pharmaceuticals, Inc. |
Director |
Restricted Stock Units |
4K |
$19.8K |
$4.95 |
Jun 5, 2024 |
Direct |
Jiya Acquisition Corp. |
Director, 10%+ Owner |
Class B Common Stock |
2.44M |
|
|
Sep 23, 2022 |
Indirect |
ALUMIS INC. |
Director |
Common Stock |
1.7M |
|
|
Jul 1, 2024 |
By Samsara BioCapital, L.P. |
Mineralys Therapeutics, Inc. |
Director, 10%+ Owner |
Stock Option |
22K |
|
|
May 22, 2024 |
Direct |
Scholar Rock Holding Corp |
Director |
Stock Option (Right to Buy) |
18K |
|
|
Jun 27, 2024 |
Direct |
Syros Pharmaceuticals, Inc. |
Director |
Stock Option (right to buy) |
6K |
|
|
Jun 5, 2024 |
Direct |
ALUMIS INC. |
Director |
Class A Common Stock |
0 |
|
|
Jul 1, 2024 |
By Samsara BioCapital, L.P. |
ALUMIS INC. |
Director |
Series C Preferred Stock |
0 |
|
|
Jul 1, 2024 |
By Samsara BioCapital, L.P. |
CHINOOK THERAPEUTICS, INC. |
Director |
Common Stock |
0 |
|
$39.03 |
Aug 11, 2023 |
By Samsara BioCapital, L.P. |
CHINOOK THERAPEUTICS, INC. |
Director |
Common Stock |
0 |
|
$39.03 |
Aug 11, 2023 |
Direct |
CHINOOK THERAPEUTICS, INC. |
Director |
Stock Option (Right to Buy) |
0 |
|
$26.12 |
Aug 11, 2023 |
Direct |
INTERCEPT PHARMACEUTICALS, INC. |
Director |
Common Stock |
0 |
|
$19.00 |
Nov 8, 2023 |
Direct |
INTERCEPT PHARMACEUTICALS, INC. |
Director |
Common Stock |
0 |
|
$19.00 |
Nov 8, 2023 |
Indirect |
INTERCEPT PHARMACEUTICALS, INC. |
Director |
Option to Purchase Common Stock |
0 |
|
|
Nov 8, 2023 |
Direct |